Skip to main content
SpringerLink
Log in

Physiology of antithrombin III

  • III. Proteins Inhibiting Coagulation and Fibrinolysis
  • Published:
Ricerca in clinica e in laboratorio

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abildgaard U.: Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis—Scand. J. clin. Lab. Invest.21, 89, 1968.

    Article  PubMed  CAS  Google Scholar 

  2. Abildgaard U.: Evidence that antithrombin III is the main inhibitor of coagulation enzymes. In:Collen D., Wilman B., Verstraete M. (Eds). The physiological inhibitors of blood coagulation and fibrinolysis. Elsevier/North-Holland, Amsterdam, 1979; p. 31.

    Google Scholar 

  3. Awbrey B. J., Hcak J. C., Owen W. G.: Binding of human thrombin to cuitured human endothelial cells—J. biol. Chem.254, 4092, 1979.

    PubMed  CAS  Google Scholar 

  4. Bjork I., Danielsson A., Fenton J., Jornvall H.: The site in human antithrombin for functional proteolytic cleavage by human thrombin.FEBS Letters126, 257, 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Buonassist V.: Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cul ture—Exp. Cell Res.76, 363, 1973.

    Article  Google Scholar 

  6. Busby T. F., Ethan D. H., Ingham K. C.: Thermal denaturation of antithrombin III. Stabilization by heparin and lyotropic anions—J. biol. Chem.256, 12140, 1981.

    PubMed  CAS  Google Scholar 

  7. Busch G., Owen W. G.: Identificationin vitro of an endothelial cell surface cofactor for antithrombin III—J. clin. Invest.69, 126, 1982.

    Article  Google Scholar 

  8. Collen D., Schetz J., DeCook F., Holmer E., Verstraete M.: Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. Europ. J. clin. Invest.7, 27, 1977.

    Article  PubMed  CAS  Google Scholar 

  9. Cosgriff T. M., Bishop D. T., Hershgold E. J., Skolnick M. H., Martin B. A., Baty B. J., Carlson K. S.: Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment—Medicine (Baltimore)62, 209, 1983.

    CAS  Google Scholar 

  10. Danielsson A., Bjork I.: Binding to antithrombin of heparin fractions with different molecular weights—Biochem. J.193, 427, 1981.

    PubMed  CAS  Google Scholar 

  11. Esmon C. T., Esmon N. L., Harris K. W.: Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation—J. biol. Chem.257, 7944, 1982.

    PubMed  CAS  Google Scholar 

  12. Fish W. W., Orre K., Bjork I.: The production of an inactive form of antithrombin through limited proteolysis by thrombin—FEBS Letters98, 103, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Hellgren M., Tengborn L., Abildgaard U.: Pregnancy in women with congenital antithrombin III deficiency: experience in treatment with heparin and antithrombin—Gynecol. Obstetr. Invest.14, 127, 1982.

    Article  CAS  Google Scholar 

  14. Hook M., Bjork I., Hopwood J., Lindahl U.: Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin—FEBS Letters66, 90, 1976.

    Article  PubMed  CAS  Google Scholar 

  15. Lam L. H., Silbert J. E., Rosenberg R. D.: The separation of active and inactive forms of heparin—Biochem. biophys. Res. Commun.69, 570, 1976.

    Article  PubMed  CAS  Google Scholar 

  16. Lam L. S. L., Regoeczi E., Hatton M. W. C.:In vivo behaviour of some antithrombin-III-protease complexes—Brit. J. exp. Pathol.60, 151, 1979.

    CAS  Google Scholar 

  17. Laurent T. C., Tengblad A., Thundberg L., Hook M., Lindahl U.: The moiecular weight-dependence of the anticoagulant activity of heparin—Biochem. J.175, 691, 1978.

    PubMed  CAS  Google Scholar 

  18. Lindahl U.: Structural basis for the biological effects of heparin. In:McDuffie M. (Ed.): Heparin: structure, cellular functions and clinical applications. Academic Press, New York-London, 1979; p. 167.

    Google Scholar 

  19. Lollar P., Owen W. G.: Clearance of thrombin from circulation in rabbits by high-affinity inding sites on endothelium—J. clin. Invest.66, 1222, 1980.

    Article  PubMed  CAS  Google Scholar 

  20. Lyttlelton J. W.: The antithrombin activity of human plasma—Biochem. J.58, 8, 1954.

    Google Scholar 

  21. Marciniak E.: Adverse effect of heparin in thrombin-antithrombin III interaction—Thrombos. Diathes. haemorrh. (Stuttg.)34, 748, 1975.

    CAS  Google Scholar 

  22. Marciniak E.: Antithrombin III and heparin inactivation in thrombin-involving reactions. Thrombos. Haemost.38, 486, 1977.

    CAS  Google Scholar 

  23. Marciniak E.: Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin—Brit. J. Haematol.48, 325, 1981.

    CAS  Google Scholar 

  24. Marciniak E.: Antithrombin III: its role as a coagulation inhibitor. In:Lusher J. M., Barnhart M. I. (Eds): Acquired bleeding disorders in children. Masson Publ. Inc., New York, 1981.

    Google Scholar 

  25. Marciniak E.: Differential role of fractionated heparin in antithrombin III proteolysis. Blood59, 576, 1982.

    PubMed  CAS  Google Scholar 

  26. Marciniak E.: Unpublished observations.

  27. Marciniak E., Gockerman J. P.: Heparin-induced decrease in circulating antithrombin-III. Lancetii, 581, 1977.

    Article  Google Scholar 

  28. Marciniak E., Gockerman J. P.: Kinetics of elimination of antithrombin III concentrate in heparinized patients—Brit. J. Haematol.48, 617, 1981.

    CAS  Google Scholar 

  29. Marciniak E., Gora-Maslak G.: Enhancement by heparin of thrombin-induced antithrombin III proteolysis: its relation to the molecular weight and anticoagulant activity of heparin. Thrombos. Res.28, 411, 1982.

    Article  CAS  Google Scholar 

  30. Marciniak E., Gora-Maslak G.: High molecular weight forms of antithrombin III complexes in blood—Thrombos. Haemost.49, 32, 1983.

    CAS  Google Scholar 

  31. Marciniak E., Gora-Maslak G.: The interaction of immobilized thrombin with human antithrombin III—Thrombos. Haemost.51, 27, 1984.

    CAS  Google Scholar 

  32. Marciniak E., Kamuf R., Brennan L. V.: Intravascular and extravascular forms of inactive antithrombin III—Thrombos. Haemost.50, 161, 1983. (Abstract).

    Google Scholar 

  33. Monkhouse F. C., France E. S., Seegers W. H.: Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminium hydroxide—Circulat. Res.3, 397, 1955.

    PubMed  CAS  Google Scholar 

  34. Rosenberg R. D., Damus P. A.: The purification and mechanism of action of human antithrombin-heparin cofactor—J. biol. Chem.248, 6490, 1973.

    PubMed  CAS  Google Scholar 

  35. Sas G., Pepper D. S.: Detection of thrombin-ATIII complex by crossed immunoelectrophoresis. Thrombos. Res.9, 95, 1976.

    Article  CAS  Google Scholar 

  36. Sas G., Pepper D. S., Cash J. D.: Investigations on antithrombin III in normal plasma and serum—Brit. J. Haematol.30, 265, 1975.

    Article  CAS  Google Scholar 

  37. Sas G., Petö I., Bánhegyi D., Blaskó G., Domján G.: Heterogeneity of the ‘classical’ antithrombin III deficiency—Thrombos. Haemost.43, 133, 1980.

    CAS  Google Scholar 

  38. Shifman M. A., Pizzo S. V.: Thein vivo metabolism of antithrombin III and antithrombin III complexes—J. biol. Chem.257, 3243, 1982.

    PubMed  CAS  Google Scholar 

  39. Teitel J. M., Bauer K. A., Lau H. K., Rosenberg R. D.: Studies on the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombin complex—Blood59, 1086, 1982.

    PubMed  CAS  Google Scholar 

  40. Wickerhauser M., Williams C., Mercer J.: Development of large scale fractionation methods. VII. Preparation of antithrombin III concentrate—Vox Sang. (Basel)36, 281, 1979.

    Article  CAS  Google Scholar 

  41. Wolf M., Boyer C., Lavergne J. M., Larrieu M. J.: A new familial variant of antithrombin III: antithrombin III Paris—Brit. J. Haematol.51, 285, 1982.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Kentucky College of Medicine, 800 Rose Street, 10536, Lexington, Ky., USA

    Ewa Marciniak

Authors
  1. Ewa Marciniak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marciniak, E. Physiology of antithrombin III. La Ricerca Clin. Lab. 14, 475–483 (1984). https://doi.org/10.1007/BF02904874

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904874

Key-words

Search

Navigation